Condition: Suicide Prevention · Suicide Threat · Self Efficacy · Sponsor: St. Olavs Hospital
The plan is to include patients with a history of increased risk of suicide. In the aftermath of an episode of imminent suicide risk, patients will receive a psychoeducational course that entails information on different aspects of suicide-related topics, identifying triggers and detecting early warning signals for increased suicide risk. The course culminates in working on completing a individual safety plan to prevent an future increase in suicide risk. The course will incorporate both patients and their next of kin. The psychoeducational course will be compared to a control group where the patients receive one individual session with focus on a safety plan to evaluate the intervention. Both groups will receive treatment as usual (TAU) during both the acute phase and follow-up. The study will be conducted as a randomized controlled trial.
This description comes directly from the study's public registry record.
Katrine K Fjukstad, PhD · +4774098600 · katrine.k.fjukstad@ntnu.no
Thine Rishaug, MD · Thine.Marita.Kirkeby.Rishaug@stolav.no
Always discuss trial participation with your own doctor first.
| Helse Nord-Trøndelag | Levanger, Trøndelag, Norway | Recruiting |
| St. Olav Hospital | Trondheim, Trøndelag, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06466356